Ftse Mib
33.837,26
0,27%
DAX
17.958,60
0,20%
S&P 500
5.018,39
0,00%
NASDAQ Composite
15.605,48
0,00%
Bitcoin
58.639,39
0,69%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Agios Pharmaceuticals Inc (AGIO) Agios Pharmaceuticals Inc (AGIO) Notizie

Agios Pharmaceuticals Inc

AGIO
33,66
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202413:00GLOBEAgios Reports Business Highlights and First Quarter 2024..
18/4/202413:00GLOBEAgios to Webcast Conference Call of First Quarter 2024..
09/4/202413:00GLOBEAgios Publishes 2024 Environmental, Social and Governance..
08/3/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202413:00GLOBEAgios to Present at the Leerink Partners Global Biopharma..
01/3/202422:27EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:26EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202403:21EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:00GLOBEAgios to Present at the TD Cowen 44th Annual Health Care..
15/2/202416:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202413:03EDGAR2Form 8-K - Current report
15/2/202413:00GLOBEAgios Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202413:00GLOBEAgios to Webcast Conference Call of Fourth Quarter and Year..
24/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:58EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAgios Announces Key Anticipated 2024 Milestones Across Rare..
05/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202412:30GLOBEAgios Announces Phase 3 ENERGIZE Study of Mitapivat Met..
02/1/202413:00GLOBEAgios to Present at the 42nd Annual J.P. Morgan Healthcare..
10/12/202301:00GLOBEAgios Presents Positive Results from Phase 2 Portion of the..
20/11/202313:00GLOBEAgios Announces Clinical Proof-of-Concept in Phase 2a Trial..
02/11/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:05GLOBEAgios Pharmaceuticals to Present Broad Set of Clinical and..
02/11/202312:02EDGAR2Form 8-K - Current report
02/11/202312:00GLOBEAgios Reports Business Highlights and Third Quarter 2023..
28/9/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202313:00GLOBEAgios to Present at the Morgan Stanley Global Healthcare..
21/8/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 33,66

La tua Cronologia

NASDAQ
AGIO
Agios Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network